Farmers Edge Sees Exercise Of Over-Allotment Option, Bringing IPO Proceeds To $143.8 Million

Farmers Edge (TSX: FDGE) has seen further capital inflows in connection with its initial public offering. The firm this morning announced that it has now received an additional $18.8 million in funds as a result of the full exercise of its over-allotment option that was issued in connection with the financing.

A total of 1.1 million common shares were issued under the over-allotment option, bringing in $18,750,150 in additional funds, with common shares of the issuer sold at a price of $17.00 each. The additional sale brings total gross proceeds from the initial public offering, or IPO, to $143.8 million.

Farmers Edge last traded at $16.47 on the TSX.


Information for this briefing was found via Farmers Edge and Sedar. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Kirkland Lake Discoveries Drills 39.35 g/t Gold Over 16.4 Metres As Mirado Continues To Grow

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Related News

PropTech SPAC Jaguar Global Growth Prices US$200 Million IPO

Special purpose acquisition company Jaguar Global Growth Corporation I (Nasdaq: JGGCU) started trading on the...

Monday, February 14, 2022, 02:12:00 PM

Shein Reportedly Filed $63 Billion London IPO Amid U.S. Regulatory Hurdles

Online fashion retailer Shein has confidentially filed papers for a potential listing in London, a...

Monday, June 24, 2024, 09:02:00 AM

SpaceX Targets Retail Investors In The Biggest IPO Yet

SpaceX is no longer just selling the biggest IPO in history, it is trying to...

Saturday, April 11, 2026, 02:05:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Edtech Firm Instructure Eyes US$250 Million IPO

Education technology company Instructure Holdings began trading on the New York Stock Exchange today under...

Thursday, July 22, 2021, 01:25:00 PM